[1]
Mead JR, Irvine SA, Ramji DP. Lipoprotein lipase: structure, function, regulation, and role in disease. Journal of molecular medicine (Berlin, Germany). 2002 Dec:80(12):753-69
[PubMed PMID: 12483461]
[2]
Beigneux AP, Allan CM, Sandoval NP, Cho GW, Heizer PJ, Jung RS, Stanhope KL, Havel PJ, Birrane G, Meiyappan M, Gill JE 4th, Murakami M, Miyashita K, Nakajima K, Ploug M, Fong LG, Young SG. Lipoprotein lipase is active as a monomer. Proceedings of the National Academy of Sciences of the United States of America. 2019 Mar 26:116(13):6319-6328. doi: 10.1073/pnas.1900983116. Epub 2019 Mar 8
[PubMed PMID: 30850549]
[3]
Arora R, Nimonkar AV, Baird D, Wang C, Chiu CH, Horton PA, Hanrahan S, Cubbon R, Weldon S, Tschantz WR, Mueller S, Brunner R, Lehr P, Meier P, Ottl J, Voznesensky A, Pandey P, Smith TM, Stojanovic A, Flyer A, Benson TE, Romanowski MJ, Trauger JW. Structure of lipoprotein lipase in complex with GPIHBP1. Proceedings of the National Academy of Sciences of the United States of America. 2019 May 21:116(21):10360-10365. doi: 10.1073/pnas.1820171116. Epub 2019 May 9
[PubMed PMID: 31072929]
[4]
Gunn KH, Roberts BS, Wang F, Strauss JD, Borgnia MJ, Egelman EH, Neher SB. The structure of helical lipoprotein lipase reveals an unexpected twist in lipase storage. Proceedings of the National Academy of Sciences of the United States of America. 2020 May 12:117(19):10254-10264. doi: 10.1073/pnas.1916555117. Epub 2020 Apr 24
[PubMed PMID: 32332168]
[5]
Falko JM. Familial Chylomicronemia Syndrome: A Clinical Guide For Endocrinologists. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2018 Aug:24(8):756-763. doi: 10.4158/EP-2018-0157. Epub
[PubMed PMID: 30183397]
[6]
Blom DJ, O'Dea L, Digenio A, Alexander VJ, Karwatowska-Prokopczuk E, Williams KR, Hemphill L, Muñiz-Grijalvo O, Santos RD, Baum S, Witztum JL. Characterizing familial chylomicronemia syndrome: Baseline data of the APPROACH study. Journal of clinical lipidology. 2018 Sep-Oct:12(5):1234-1243.e5. doi: 10.1016/j.jacl.2018.05.013. Epub 2018 May 31
[PubMed PMID: 30318066]
[7]
Yuan G, Al-Shali KZ, Hegele RA. Hypertriglyceridemia: its etiology, effects and treatment. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2007 Apr 10:176(8):1113-20
[PubMed PMID: 17420495]
[8]
Blackett P, Tryggestad J, Krishnan S, Li S, Xu W, Alaupovic P, Quiroga C, Copeland K. Lipoprotein abnormalities in compound heterozygous lipoprotein lipase deficiency after treatment with a low-fat diet and orlistat. Journal of clinical lipidology. 2013 Mar-Apr:7(2):132-9. doi: 10.1016/j.jacl.2012.11.006. Epub 2012 Dec 12
[PubMed PMID: 23415432]
[9]
Okopień B, Bułdak Ł, Bołdys A. Benefits and risks of the treatment with fibrates--a comprehensive summary. Expert review of clinical pharmacology. 2018 Nov:11(11):1099-1112. doi: 10.1080/17512433.2018.1537780. Epub 2018 Oct 23
[PubMed PMID: 30328735]
[10]
Kobayashi J, Mabuchi H. Lipoprotein lipase and atherosclerosis. Annals of clinical biochemistry. 2015 Nov:52(Pt 6):632-7. doi: 10.1177/0004563215590451. Epub 2015 May 20
[PubMed PMID: 25995285]